Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone for Cognition in Schizophrenia
NCT00178971Phase 3Completed
- Sponsor
- Northwestern University
- Start
- Jan 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buspirone in schizophrenia, schizoaffective disorder, sponsored by Northwestern University. Started Jan 2003; status: completed.
02
Drugs
buspirone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00178971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178971.